<i>MTHFR</i> Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment.
| Author | |
| Abstract |
:
This post hoc analysis of the CSPPT (China Stroke Primary Prevention Trial) assessed the individual variation in total homocysteine (tHcy)-lowering response after an average 4.5 years of 0.8 mg daily folic acid therapy in Chinese hypertensive adults and evaluated effect modification by methylenetetrahydrofolate reductase (MTHFR) C677T genotypes and serum folate levels. |
| Year of Publication |
:
2018
|
| Journal |
:
Arteriosclerosis, thrombosis, and vascular biology
|
| Date Published |
:
2018
|
| ISSN Number |
:
1079-5642
|
| DOI |
:
10.1161/ATVBAHA.117.310211
|
| Short Title |
:
Arterioscler Thromb Vasc Biol
|
| Download citation |
